Publications by authors named "Cheng-Di Weng"

Claim this Profile
T
Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced -mutated non-small cell lung cancer patients.
Cheng-Di Weng, Ke-Jun Liu, Shi Jin, Jun-Wei Su, Yi-Hui Yao

Transl Lung Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma ddPCR for the detection of amplification in advanced NSCLC patients: a comparative real-world study.
Jun-Wei Su, Cheng-Di Weng, Xiao-Cheng Lin, Mei-Mei Fang, Xiao Xiao

Ther Adv Med Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis